Joseph L. Goldstein, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 2,327 shares at $482.82 ($1.1M) on 2020-03-09, disclosed to the SEC on 2020-03-10.
Open-market sale of $1.1M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $468.14 | 200 | $94K | 8.5% |
| 2 | $469.80 | 100 | $47K | 4.2% |
| 3 | $470.83 | 200 | $94K | 8.5% |
| 4 | $471.34 | 100 | $47K | 4.3% |
| 5 | $474.88 | 73 | $35K | 3.1% |
| 6 | $475.31 | 327 |
| $155K |
| 14.0% |
| 7 | $475.31 | 327 | $155K | 14.0% |
| 8 | $476.16 | 200 | $95K | 8.6% |
| 9 | $479.21 | 500 | $240K | 21.6% |
| 10 | $482.82 | 300 | $145K | 13.1% |
| Total | $475.77 avg | 2,327 | $1.1M | 100% |
| Filing → |
| REGN | SELL | 2022-04-01 | $1.7M | — | Filing → |
| REGN | SELL | 2021-09-13 | $1.6M | — | Filing → |
| REGN | SELL | 2021-06-08 | $1.0M | — | Filing → |